Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial
PaperCitations, authors & open-access status
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 730 citations, 2018 year and green oa status.
730
Citations
2018
Year
green
OA Status